Place of pegvisomant in acromegaly.
Ho
K K
KK
Garvan Institute of Medical Research, St Vincent's Hospital, NSW 2010, Sydney, Australia. k.ho@garvan.org.au
D000172:Acromegaly / Q000188:drug therapy* / Q000601:surgery; D019382:Human Growth Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D011986:Receptors, Somatotropin / Q000037:antagonists & inhibitors*
D011986:Receptors, Somatotropin; D019382:Human Growth Hormone; C406545:pegvisomant